MODERATE-TO-SEVERE BENIGN PROSTATIC HYPERPLASIA (BPH)

Clinical trials for MODERATE-TO-SEVERE BENIGN PROSTATIC HYPERPLASIA (BPH) explained in plain language.

Never miss a new study

Get alerted when new MODERATE-TO-SEVERE BENIGN PROSTATIC HYPERPLASIA (BPH) trials appear

Sign up with your email to follow new studies for MODERATE-TO-SEVERE BENIGN PROSTATIC HYPERPLASIA (BPH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New formulation of prostate drug put to the test in healthy volunteers

Knowledge-focused Recruiting now

This study compares a new formulation (AJU-G721) of a drug used for benign prostatic hyperplasia (BPH) to the original version (G721R) in healthy adult men. The goal is to see if the two versions are absorbed and processed by the body in the same way. Participants receive a singl…

Matched conditions: MODERATE-TO-SEVERE BENIGN PROSTATIC HYPERPLASIA (BPH)

Phase: PHASE1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Knowledge-focused

Last updated Jun 27, 2026 13:05 UTC

MODERATE-TO-SEVERE BENIGN PROSTATIC HYPERPLASIA (BPH)

Get alerted when new MODERATE-TO-SEVERE BENIGN PROSTATIC HYPERPLASIA (BPH) trials appear

New formulation of prostate drug put to the test in healthy volunteers